Reference
Mahmoudi M, et al. The Cost-Effectiveness of Oral Direct Factor Xa Inhibitors Compared with Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement Surgery. Pharmacotherapy : 26 Apr 2013. Available from: URL: http://dx.doi.org/10.1002/phar.1269
Rights and permissions
About this article
Cite this article
Oral direct factor Xa inhibitors carry their weight. PharmacoEcon Outcomes News 678, 9 (2013). https://doi.org/10.1007/s40274-013-0405-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0405-7